Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

novartis consumer health b.v. - polysulfated glycosaminoglycan 100 mg/ml - solution for injection - 500 mg/5ml - glycosaminoglycan polysulfate 100 mg/ml - glucosaminoglycan polysulfate - horse

Canada - English - Health Canada

american regent, inc - glycosaminoglycan polysulfate - solution - 250mg - glycosaminoglycan polysulfate 250mg - horses

Canada - English - Health Canada

american regent, inc - glycosaminoglycan polysulfate - solution - 100mg - glycosaminoglycan polysulfate 100mg - horses

Canada - English - Health Canada

american regent, inc - glycosaminoglycan polysulfate - solution - 100mg - glycosaminoglycan polysulfate 100mg - dogs

United States - English - NLM (National Library of Medicine)

professional group of pharmacists new york llc - pentosan polysulfate sodium (unii: 914032762y) (pentosan polysulfate - unii:f59p8b75r4) -

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - glycosaminoglycan polysulfate - parenteral liquid/solution/suspension - glycosaminoglycan polysulfate emulsifiers & surfactants active 100.0 mg/ml - musculoskeletal system - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - degenerative aseptic joint disease | traumatic degenerative joint d

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - glycosaminoglycan polysulfate - parenteral liquid/solution/suspension - glycosaminoglycan polysulfate emulsifiers & surfactants active 250.0 mg/ml - musculoskeletal system - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - degenerative aseptic joint disease | traumatic degenerative joint d

Australia - English - Department of Health (Therapeutic Goods Administration)

arthropharm pty ltd - pentosan polysulfate sodium, quantity: 100 mg - capsule, hard - excipient ingredients: microcrystalline cellulose; magnesium stearate; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; ethanol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide; titanium dioxide; gelatin; sodium lauryl sulfate; silicon dioxide - indications as at 5 august 2021: elmiron is indicated for the treatment of interstitial cystitis. relief of symptoms in patients with interstitial cystitis may not be experienced until 6 to 8 weeks of therapy with elmiron. continuing long-term therapy is necessary for persistent relief of symptoms. relief of symptoms may not occur in all patients, and relapse is likely to occur gradually if treatment is discontinued, even after long periods of therapy.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ceva animal health pty ltd - pentosan polysulfate sodium - unknown - pentosan polysulfate sodium mineral-sodium active 0.0 - active constituent

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

randlab australia pty ltd - pentosan polysulfate sodium - unknown - pentosan polysulfate sodium mineral-sodium active 0.0 - active constituent